Revolution Medicines Inc
(RVMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 7,014 | 15,330 | 3,356 | 9,116 | 7,578 |
| Gross Profit | 7,014 | 15,330 | 3,356 | 9,116 | 7,578 |
| Operating Expenses | 82,171 | 77,038 | 79,889 | 71,205 | 65,527 |
| Operating Income | -75,157 | -61,708 | -76,533 | -62,089 | -57,949 |
| Other Income | 7,059 | 5,078 | 2,907 | 867 | 302 |
| Pre-tax Income | -68,098 | -56,630 | -73,626 | -61,222 | -57,647 |
| Income Tax | N/A | -123 | -297 | N/A | N/A |
| Net Income Continuous | -68,098 | -56,507 | -73,329 | -61,222 | -57,647 |
| Net Income | $-68,098 | $-56,507 | $-73,329 | $-61,222 | $-57,647 |
| EPS Basic Total Ops | -0.72 | -0.61 | -0.87 | -0.82 | -0.78 |
| EPS Basic Continuous Ops | -0.72 | -0.62 | -0.87 | -0.82 | -0.78 |
| EPS Diluted Total Ops | -0.72 | -0.61 | -0.87 | -0.82 | -0.78 |
| EPS Diluted Continuous Ops | -0.72 | -0.62 | -0.87 | -0.82 | -0.78 |
| EBITDA(a) | $-76,201 | $-61,701 | $-75,261 | $-59,728 | $-55,011 |